Immediate Treatment of Anaphylaxis
The immediate first-line treatment for anaphylaxis is prompt administration of intramuscular epinephrine, which should be given without delay at the first signs of a systemic allergic reaction. 1, 2
Initial Management Algorithm
Administer epinephrine immediately:
Position the patient appropriately:
Establish and maintain airway:
- Administer oxygen if available 1
- Monitor oxygen saturation
- Be prepared for intubation if severe respiratory distress occurs
Administer IV fluids for hypotension:
Severity-Based Management
Grade II reactions (systemic reaction without life-threatening features)
- IV epinephrine 20 μg if clinically indicated
- If unresponsive after 2 minutes, administer 50 μg IV epinephrine 2
Grade III reactions (life-threatening hypotension or bronchospasm)
- IV epinephrine 50-100 μg
- If unresponsive after 2 minutes, administer 200 μg IV epinephrine 2
Grade IV reactions (cardiac or respiratory arrest)
- Follow advanced life support protocols
- IV epinephrine 1 mg
- Initiate cardiac compressions for inadequate cardiac output 2
Refractory Management (inadequate response after 10 minutes)
- Escalate epinephrine dose (double the bolus dose)
- Start epinephrine infusion (0.05-0.1 μg/kg/min)
- Consider epinephrine infusion after three bolus doses
- Escalate fluid administration up to 20-30 mL/kg 2
Special Considerations
- Patients on beta-blockers: Consider IV glucagon 1-2 mg if poor response to epinephrine 2, 1
- Pregnant patients: Early treatment with IV epinephrine is recommended; consider emergency cesarean section if persistent hypotension despite resuscitation 2
- Mastocytosis patients: Use caution with histamine-releasing agents; premedication with H1/H2 antagonists and corticosteroids may be beneficial 2
Adjunctive Therapies (only after epinephrine)
- Antihistamines: May be administered after adequate epinephrine and fluid resuscitation, but not a priority 2
- Corticosteroids: May be given after adequate resuscitation 2
- Bronchodilators: Consider for persistent bronchospasm 2
Common Pitfalls to Avoid
- Delayed epinephrine administration: The most common and dangerous error in anaphylaxis management 1, 4
- Relying solely on antihistamines: These should never replace epinephrine as first-line treatment 1
- Improper route of administration: Intramuscular injection in the anterolateral thigh achieves higher and more rapid plasma concentrations than subcutaneous or intramuscular injection in the arm 2, 5
- Insufficient monitoring: Observe patients for at least 6 hours after symptom resolution due to risk of biphasic reactions 2, 1
- Epinephrine overdose: Can cause serious adverse effects; follow recommended dosing 4
Post-Treatment Observation
- Monitor in a supervised setting for a minimum of 6 hours or until stable with regressing symptoms 2
- Longer observation (up to 24 hours) may be warranted for patients with severe reactions, those requiring multiple epinephrine doses, or those with risk factors for biphasic reactions 1, 6
Remember that there are no contraindications to epinephrine administration in patients experiencing anaphylaxis, and the benefits far outweigh the risks even in patients with cardiovascular disease 2.